Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations

ConclusionsDelamanid is a relatively safe drug with few side effects. However, some patients could not continue it because of difficulty of use in combination, therefore delamanid should be prescribed considering the side effects of all therapies in the regimen.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research